Literature DB >> 17363695

Grb2 is required for atherosclerotic lesion formation.

Brandon M Proctor1, Jie Ren, Zhouji Chen, Jochen G Schneider, Trey Coleman, Traian S Lupu, Clay F Semenkovich, Anthony J Muslin.   

Abstract

OBJECTIVE: Grb2 is a ubiquitously expressed linker protein that couples growth factor receptor activation to downstream mitogen-activated protein kinase (MAPK) cascades. Macrophage proliferation and uptake of modified lipoproteins are critical components of atherogenesis which require MAPK activation. However, the precise role of upstream signaling factors and the interrelationship of various MAPK cascades in the pathogenesis of atherosclerosis remains uncertain. Complete deletion of Grb2 in mice results in early embryonic lethality. However, Grb2 heterozygous mice appear normal at birth. To test the role of the Grb2 adapter protein in atherosclerotic lesion formation, we generated Grb2+/- mice in the apoE-/- genetic background. METHODS AND
RESULTS: Grb2+/- apoE-/- and apoE-/- mice exhibited similar body weight and serum lipid profiles. However, Grb2+/- apoE-/- mice on a Western diet had reduced lesion formation compared with apoE-/- mice by aortic sinus and en face assays. Transplantation of apoE-/- mice with Grb2+/- apoE-/- or apoE-/- bone marrow indicated that Grb2 haploinsufficiency in blood-borne cells confers resistance to Western diet-induced atherosclerosis. Cell culture experiments with bone marrow-derived macrophages showed that Grb2 is required for oxidized low density lipoprotein (oxLDL)-induced MAPK activation and foam cell formation.
CONCLUSIONS: Grb2 is required for atherosclerotic lesion formation and uptake of oxidized LDL by macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363695     DOI: 10.1161/ATVBAHA.106.134007

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis.

Authors:  Chunhong Mao; Timothy D Howard; Dan Sullivan; Zongming Fu; Guoqiang Yu; Sarah J Parker; Rebecca Will; Richard S Vander Heide; Yue Wang; James Hixson; Jennifer Van Eyk; David M Herrington
Journal:  J Proteom Genom Res       Date:  2017-03-04

Review 2.  MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.

Authors:  Anthony J Muslin
Journal:  Clin Sci (Lond)       Date:  2008-10       Impact factor: 6.124

3.  Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium.

Authors:  Fabrizio Montecucco; Vincent Braunersreuther; Giorgio Luciano Viviani; Sébastien Lenglet; François Mach
Journal:  Curr Signal Transduct Ther       Date:  2012-05

4.  Systematic analysis of the molecular mechanism underlying atherosclerosis using a text mining approach.

Authors:  Dan Xi; Jinzhen Zhao; Wenyan Lai; Zhigang Guo
Journal:  Hum Genomics       Date:  2016-06-02       Impact factor: 4.639

5.  Is Immune Suppression Involved in the Ischemic Stroke? A Study Based on Computational Biology.

Authors:  Xin Wang; Qian Wang; Kun Wang; Qingbin Ni; Hu Li; Zhiqiang Su; Yuzhen Xu
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.750

6.  The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.

Authors:  Yuyan Dong; Juxiang Liu; Jing Ma; Jinxing Quan; Yanxia Bao; Yaqiang Cui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.